Blavatnik Biomedical Overview
- Investor Type
-
Accelerator/Incubator
- Status
-
Active
- Investments
-
2
- Portfolio
-
1
- Exits
-
1
Blavatnik Biomedical General Information
Description
Blavatnik Biomedical is an accelerator that bridges the gap between innovative, early-stage life science research and successful development of high-impact biomedical products. The firm's integrated approach combines essential funding with development and business expertise, leading to commercial partnerships that bring forth new biomedical discoveries that create value and benefit society.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Accelerator/Incubator
Primary Office
- 1350 Massachusetts Avenue
- Cambridge, MA 02138
- United States
+1 (617) 000-0000
Blavatnik Biomedical Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| StemCellerant | 08-Jun-2017 | Accelerator/Incubator | Other Pharmaceuticals and Biotechnology | Generating Revenue | ||
| 000000 00000000000 | 000000000000 | Drug Discovery | Generating Revenue |
Blavatnik Biomedical Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| 000000 00000000000 | 01-Apr-2021 | 000000000000000000 | 000.00 |
Blavatnik Biomedical Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
